• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于校正体重和总体重计算舒更葡糖钠剂量对病态肥胖患者深度神经肌肉阻滞逆转的疗效和安全性。

Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients.

机构信息

Department of Anesthesiology, Fourth Affiliated Hospital of China Medical University, Shenyang, China.

Department of General Surgery, Fourth Affiliated Hospital of China Medical University, Shenyang, China.

出版信息

J Int Med Res. 2021 Jan;49(1):300060520985679. doi: 10.1177/0300060520985679.

DOI:10.1177/0300060520985679
PMID:33499679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7844457/
Abstract

OBJECTIVE

We investigated the efficacy and safety of sugammadex doses calculated using corrected body weight (CBW) for reversing deep rocuronium-induced neuromuscular blockade (NMB) in morbidly obese patients undergoing laparoscopic bariatric surgery.

METHODS

One hundred and twenty-five morbidly obese patients were randomly assigned to three groups: (1) a CBW group, n = 50; (2) a total body weight (TBW) group, n = 50; and (3) a control group, n = 25. Deep NMB was maintained using a continuous infusion of rocuronium. At the reappearance of 1 to 2 post-tetanic counts (PTCs), 4 mg/kg sugammadex, calculated using CBW or TBW, were administered.

RESULTS

All the participants in the CBW and TBW groups recovered to a train-of-four (TOF) ratio of 0.9 within 5 minutes. The recovery times from the start of sugammadex administration to a TOF ratio of 0.9 were 2.2 ± 0.7 and 2.0 ± 0.7 minutes in the CBW and TBW groups, respectively. Thus, a sugammadex dose calculated using CBW was not inferior to that calculated using TBW for the reversal of rocuronium-induced deep NMB in morbidly obese patients.

CONCLUSION

A dose of 4 mg/kg of sugammadex calculated using CBW is efficient and safe for the reversal of deep NMB after a continuous infusion of rocuronium in morbidly obese patients.

CLINICAL TRIAL REGISTRATION NUMBER

ChiCTR1900028652 (Chinese Clinical Trial Registry, www.chictr.org.cn).

摘要

目的

我们研究了使用矫正体重(CBW)计算的舒更葡糖钠剂量在腹腔镜减重手术的病态肥胖患者中逆转深度罗库溴铵诱导的神经肌肉阻滞(NMB)的疗效和安全性。

方法

125 名病态肥胖患者被随机分为三组:(1)CBW 组,n=50;(2)总体重(TBW)组,n=50;和(3)对照组,n=25。通过罗库溴铵持续输注维持深度 NMB。在出现 1 到 2 个强直后计数(PTC)时,给予 4mg/kg 舒更葡糖钠,根据 CBW 或 TBW 计算。

结果

CBW 和 TBW 组的所有患者均在 5 分钟内恢复至 4 个成串刺激(TOF)比值 0.9。从舒更葡糖钠给药开始到 TOF 比值为 0.9 的恢复时间分别为 CBW 和 TBW 组的 2.2±0.7 分钟和 2.0±0.7 分钟。因此,使用 CBW 计算的舒更葡糖钠剂量与使用 TBW 计算的剂量一样,在病态肥胖患者中逆转罗库溴铵诱导的深度 NMB 是有效的。

结论

对于病态肥胖患者连续输注罗库溴铵后,使用 CBW 计算的 4mg/kg 舒更葡糖钠剂量是一种有效且安全的深度 NMB 逆转方法。

临床试验注册号

ChiCTR1900028652(中国临床试验注册中心,www.chictr.org.cn)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b06e/7844457/15b8923914fb/10.1177_0300060520985679-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b06e/7844457/42593d3ec5c1/10.1177_0300060520985679-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b06e/7844457/15b8923914fb/10.1177_0300060520985679-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b06e/7844457/42593d3ec5c1/10.1177_0300060520985679-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b06e/7844457/15b8923914fb/10.1177_0300060520985679-fig2.jpg

相似文献

1
Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients.基于校正体重和总体重计算舒更葡糖钠剂量对病态肥胖患者深度神经肌肉阻滞逆转的疗效和安全性。
J Int Med Res. 2021 Jan;49(1):300060520985679. doi: 10.1177/0300060520985679.
2
Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials.肥胖患者罗库溴铵/维库溴铵诱导肌松效应逆转时适宜给予琥珀酰明胶的剂量:一项随机对照试验的荟萃分析。
J Int Med Res. 2022 Aug;50(8):3000605221116760. doi: 10.1177/03000605221116760.
3
Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.罗库溴铵诱导的长时间深度神经肌肉阻滞的恢复:舒更葡糖钠逆转与自然恢复的随机对照比较
Anaesthesist. 2015 Jul;64(7):506-12. doi: 10.1007/s00101-015-0048-0. Epub 2015 Jul 1.
4
Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.罗库溴铵诱导全身麻醉下病态肥胖患者肌松作用逆转时,琥珀酸舒更葡糖钠与新斯的明的随机对照比较。
Br J Anaesth. 2012 Feb;108(2):236-9. doi: 10.1093/bja/aer330. Epub 2011 Oct 19.
5
Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.舒更葡糖钠逆转罗库溴铵和维库溴铵诱发神经肌肉阻滞的疗效:26 项研究的汇总分析。
J Clin Anesth. 2017 Sep;41:84-91. doi: 10.1016/j.jclinane.2017.06.006. Epub 2017 Jul 15.
6
Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients.适当给予 sugammadex 逆转病态肥胖患者罗库溴铵所致深度神经肌肉阻滞。
Anaesthesia. 2016 Mar;71(3):265-72. doi: 10.1111/anae.13344. Epub 2015 Dec 19.
7
Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.基于理想体重比较三种不同剂量琥珀酸舒更葡糖钠逆转腹腔镜减重手术中中效罗库溴铵诱导的神经肌肉阻滞。
Minerva Anestesiol. 2017 Feb;83(2):138-144. doi: 10.23736/S0375-9393.16.11349-5. Epub 2016 Aug 30.
8
Reversal of neuromuscular blockade by sugammadex in laparoscopic bariatric surgery: In support of dose reduction.在腹腔镜减重手术中用 sugammadex 逆转神经肌肉阻滞:支持减少剂量。
Anaesth Crit Care Pain Med. 2016 Feb;35(1):25-29. doi: 10.1016/j.accpm.2015.09.003. Epub 2015 Nov 17.
9
Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.在接受肝脏手术的肝功能不全患者中持续输注罗库溴铵后,舒更葡糖钠对神经肌肉阻滞的快速逆转作用。
Acta Anaesthesiol Taiwan. 2014 Jun;52(2):54-8. doi: 10.1016/j.aat.2014.04.007. Epub 2014 Jun 6.
10
Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.4mg/kg 琥珀酸舒更葡糖钠用于治疗重度肾功能损害患者深度神经肌肉阻滞逆转的疗效、安全性和药代动力学。
Br J Anaesth. 2015 May;114(5):777-84. doi: 10.1093/bja/aet586. Epub 2015 Mar 31.

引用本文的文献

1
Effects of Different Body Mass Indexes on the Induction Dose of Remimazolam in Patients Undergoing Gynaecological Day Surgery: A Propensity Score-Matched Study.不同体重指数对妇科日间手术患者瑞马唑仑诱导剂量的影响:一项倾向评分匹配研究
Drug Des Devel Ther. 2025 Aug 22;19:7285-7292. doi: 10.2147/DDDT.S542292. eCollection 2025.
2
The Dosage of Muscle Relaxants in Morbidly Obese Patients in Daily Practice - A Narrative Review.日常实践中肥胖患者的肌肉松弛剂剂量——一项叙述性综述
Int J Gen Med. 2024 Sep 14;17:4055-4060. doi: 10.2147/IJGM.S474221. eCollection 2024.
3
Comparison of Different Weight Scalars to Dose Sugammadex for the Reversal of Neuromuscular Blockade in Morbidly Obese Patients: A Systematic Review.

本文引用的文献

1
Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study.成年人的体重变化与全因和特定原因死亡率的关系:前瞻性队列研究。
BMJ. 2019 Oct 16;367:l5584. doi: 10.1136/bmj.l5584.
2
Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.袖状胃切除术与 Roux-en-Y 胃旁路术与单吻合口胃旁路术的长期随访:减肥和缓解合并症的前瞻性随机对照研究。
Surg Endosc. 2019 Feb;33(2):401-410. doi: 10.1007/s00464-018-6307-9. Epub 2018 Jun 25.
3
不同体重标量与舒更葡糖钠用于肥胖患者神经肌肉阻滞逆转的剂量比较:一项系统评价
Cureus. 2024 Mar 27;16(3):e57057. doi: 10.7759/cureus.57057. eCollection 2024 Mar.
4
Predicting the best fit based on the synergistic interaction of remifentanil and propofol at the corrected dose in elderly patients undergoing painless gastroscopy.基于瑞芬太尼与丙泊酚在老年无痛胃镜检查患者校正剂量下的协同相互作用预测最佳配伍。
Am J Transl Res. 2022 Nov 15;14(11):8390-8397. eCollection 2022.
5
Sugammadex to Facilitate Neurologic Assessment in Severely Brain-Injured Patients: A Retrospective Analysis and Practical Guidance.舒更葡糖钠用于促进重度脑损伤患者的神经功能评估:一项回顾性分析及实用指南
Cureus. 2022 Oct 19;14(10):e30466. doi: 10.7759/cureus.30466. eCollection 2022 Oct.
6
Appropriate dosing of sugammadex for reversal of rocuronium-/vecuronium-induced muscle relaxation in morbidly obese patients: a meta-analysis of randomized controlled trials.肥胖患者罗库溴铵/维库溴铵诱导肌松效应逆转时适宜给予琥珀酰明胶的剂量:一项随机对照试验的荟萃分析。
J Int Med Res. 2022 Aug;50(8):3000605221116760. doi: 10.1177/03000605221116760.
7
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update.减重手术围手术期护理指南:术后加速康复(ERAS)学会推荐意见:2021年更新版
World J Surg. 2022 Apr;46(4):729-751. doi: 10.1007/s00268-021-06394-9. Epub 2022 Jan 4.
[Sugammadex by ideal body weight versus 20% and 40% corrected weight in bariatric surgery - double-blind randomized clinical trial].
[肥胖症手术中按理想体重与20%及40%校正体重使用舒更葡糖钠——双盲随机临床试验]
Braz J Anesthesiol. 2018 May-Jun;68(3):219-224. doi: 10.1016/j.bjan.2017.10.010. Epub 2018 Jan 5.
4
Consensus Statement on Perioperative Use of Neuromuscular Monitoring.围术期使用神经肌肉监测专家共识
Anesth Analg. 2018 Jul;127(1):71-80. doi: 10.1213/ANE.0000000000002670.
5
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.舒更葡糖钠与新斯的明在成人中逆转神经肌肉阻滞的疗效与安全性比较
Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763.
6
Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial.深度神经肌肉阻滞改善减重手术中的手术条件并减轻术后疼痛:一项随机双盲对照试验。
PLoS One. 2016 Dec 9;11(12):e0167907. doi: 10.1371/journal.pone.0167907. eCollection 2016.
7
Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.基于理想体重比较三种不同剂量琥珀酸舒更葡糖钠逆转腹腔镜减重手术中中效罗库溴铵诱导的神经肌肉阻滞。
Minerva Anestesiol. 2017 Feb;83(2):138-144. doi: 10.23736/S0375-9393.16.11349-5. Epub 2016 Aug 30.
8
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.1975年至2014年200个国家成人身体质量指数的趋势:对1698项基于人群测量研究的汇总分析,涉及1920万参与者。
Lancet. 2016 Apr 2;387(10026):1377-1396. doi: 10.1016/S0140-6736(16)30054-X.
9
Appropriate dosing of sugammadex to reverse deep rocuronium-induced neuromuscular blockade in morbidly obese patients.适当给予 sugammadex 逆转病态肥胖患者罗库溴铵所致深度神经肌肉阻滞。
Anaesthesia. 2016 Mar;71(3):265-72. doi: 10.1111/anae.13344. Epub 2015 Dec 19.
10
Use of Sugammadex in Patients With Obesity: A Pooled Analysis.肥胖患者中使用苏伽(Sugammadex):汇总分析。
Am J Ther. 2017 Sep/Oct;24(5):e507-e516. doi: 10.1097/MJT.0000000000000305.